The life science group Sartorius and UK-based startup SPARTA Biodiscovery have agreed to partner on SPARTA’s analysis platform, which helps speed up the development, manufacture, and quality control of nanoparticles for biopharmaceutical drugs. Nanoparticles are small polymer or lipid capsules that act as carriers to deliver active agents to the target cells. As part of the cooperation, Sartorius will invest up to 3.5 million British pounds in a minority shareholding in SPARTA Biodiscov

Roquette, a global leader in plant-based ingredients and a leading provider of pharmaceutical and nutraceutical excipients, is set to unveil its extensive range of excipients for moisture protection – including three new product grades – at CPHI Barcelona next month. The versatile portfolio offers enhanced stability and moisture protection for sensitive formulations, as well as providing pharmaceutical and nutraceutical manufacturers with a comprehensive range of low water activit

With a mission to accelerate the pace of genomics, Integrated DNA Technologies (IDT), a leading provider of differentiated next generation sequencing (NGS) solutions, announces the availability of xGen NGS products designed exclusively for the Ultima Genomics UG 100™ platform. The suite of new xGen NGS tools comprised of adapters, primers, and universal blockers can support a wide range of applications, including DNA, RNA and methylation sequencing workflows, as well as IDT’s prov

Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (Alpha Cognition “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, is pleased to announce the submission of a New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) for ALPHA-1062, a proprietary, patented, delayed release oral tablet formulation in development for the treatment of mild-to-moderate

Emmes,a global, full-service Contract Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, announces the addition of telehealth capabilities within Advantage eClinical. The new application means any scheduled visit can become virtual with video calls augmented directly through the platform and patients signing in through their existing participant portal. Advantage eClinical is designed to enable a simple, intuitive experience

The bromine market is expected to be valued at US$ 2.53 billion in 2023. The bromine market is expected to reach US$ 4.7 Billion by 2033. The market revenue is likely to continue to expand at a CAGR of 6.3%. Bromine Market Trends and Highlights Bromine is a liquid element that occurs naturally. In agriculture and sanitation, bromine products are used as pesticides, fumigants, and fire retardants. Many citrus-flavored drinks use bromine as an emulsifier as

The newly developed Freeze-Light-Protect syringe label from Schreiner MediPharm is suitable for deep-freeze applications at temperatures far below zero and at the same time offers individual light protection. Consequently, it is particularly well-suited for use with sensitive mRNA-based substances as well as for cell and gene therapies. Schreiner MediPharm is going to present this innovative label for the first time at this year’s PDA Universe of Pre-Filled Syringes and Injection Device

SpineX Inc., a clinical stage bioelectric medtech company, is pleased to announce receipt of funding from the National Institutes of Health (NIH) through the Small Business Innovation Research Awards (SBIR). These funds will go towards completing a pivotal clinical trial to test the efficacy and safety of our proprietary SCiP™ device in children living with Cerebral Palsy (CP). The clinical trial will support efforts to seek approval to market from the US Food and Drug Adminis